Role of the Mannose Receptor in a Murine Model of Cryptococcus neoformans Infection

ABSTRACT Cryptococcus neoformans is an encapsulated fungal pathogen with a predilection to infect persons with suppressed T-cell function. Cryptococcal mannoproteins (MP) are highly mannosylated antigens which elicit T-cell responses in infected mice and in convalescent patients. Key to the immunogenicity of MP is its capacity to bind to the conserved mannose receptor (MR), CD206, on dendritic cells (DCs). To test the role of the MR in the immune response to C. neoformans, wild-type and MR knockout (MR KO) mice were compared by using in vivo and ex vivo models of cryptococcosis. Following a pulmonary challenge with C. neoformans, MR KO mice died significantly faster than wild-type mice and had higher lung fungal burdens after 4 weeks of infection. Uptake of MP was similar when DCs obtained from wild-type and MR KO mice were compared. Additionally, MP did not upregulate the maturation markers major histocompatibility complex class II, CD86, and CD40 in either wild-type or MR KO DCs. However, MP stimulated lymphoproliferation in CD4+ T cells obtained from the peripheral lymph nodes of infected wild-type but not MR KO mice. These studies demonstrate a nonredundant role for the MR in the development of CD4+ T-cell responses to MP and protection from C. neoformans.

[1]  Jennifer P. Wang,et al.  Cooperative Stimulation of Dendritic Cells by Cryptococcus neoformans Mannoproteins and CpG Oligodeoxynucleotides , 2008, PloS one.

[2]  Gesine Hansen,et al.  IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans1 , 2007, The Journal of Immunology.

[3]  S. Levitz,et al.  Effect of Differential N-linked and O-linked Mannosylation on Recognition of Fungal Antigens by Dendritic Cells , 2007, PloS one.

[4]  R. Steinman,et al.  Taking dendritic cells into medicine , 2007, Nature.

[5]  C. Specht,et al.  Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein. , 2007, The Journal of infectious diseases.

[6]  S. Levitz,et al.  Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. , 2007, Vaccine.

[7]  S. Levitz,et al.  Direct Inhibition of T-Cell Responses by the Cryptococcus Capsular Polysaccharide Glucuronoxylomannan , 2006, PLoS pathogens.

[8]  J. Heitman,et al.  The biology of the Cryptococcus neoformans species complex. , 2006, Annual review of microbiology.

[9]  S. Levitz,et al.  In Vivo Role of Dendritic Cells in a Murine Model of Pulmonary Cryptococcosis , 2006, Infection and Immunity.

[10]  C. Specht,et al.  The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. , 2006, FEMS yeast research.

[11]  E. Latz,et al.  Cryptococcus neoformans Glycoantigens Are Captured by Multiple Lectin Receptors and Presented by Dendritic Cells1 , 2006, The Journal of Immunology.

[12]  C. Specht,et al.  A Model Vaccine Exploiting Fungal Mannosylation to Increase Antigen Immunogenicity1 , 2005, The Journal of Immunology.

[13]  D. Pietrella,et al.  Mannoproteins from Cryptococcus neoformans Promote Dendritic Cell Maturation and Activation , 2005, Infection and Immunity.

[14]  S. Gordon,et al.  The mannose receptor: linking homeostasis and immunity through sugar recognition. , 2005, Trends in immunology.

[15]  S. Levitz,et al.  Opsonic Requirements for Dendritic Cell-Mediated Responses to Cryptococcus neoformans , 2005, Infection and Immunity.

[16]  S. Gordon,et al.  Ligand recognition by antigen-presenting cell C-type lectin receptors , 2004, Current Opinion in Immunology.

[17]  S. Shoham,et al.  Involvement of CD14, Toll-Like Receptors 2 and 4, and MyD88 in the Host Response to the Fungal Pathogen Cryptococcus neoformans In Vivo , 2004, Infection and Immunity.

[18]  A. Imrich,et al.  Pneumocystis Activates Human Alveolar Macrophage NF-κB Signaling through Mannose Receptors , 2004, Infection and Immunity.

[19]  M. Mansour,et al.  Protective Efficacy of Antigenic Fractions in Mouse Models of Cryptococcosis , 2004, Infection and Immunity.

[20]  P. Allavena,et al.  Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program 1 , 2003, The Journal of Immunology.

[21]  M. Nussenzweig,et al.  Absence of the Macrophage Mannose Receptor in Mice Does Not Increase Susceptibility to Pneumocystis carinii Infection In Vivo , 2003, Infection and Immunity.

[22]  M. Nussenzweig,et al.  Normal Host Defense during Systemic Candidiasis in Mannose Receptor-Deficient Mice , 2003, Infection and Immunity.

[23]  E. Amankwah,et al.  Primary Dendritic Cells Phagocytose Cryptococcus neoformans via Mannose Receptors and Fcγ Receptor II for Presentation to T Lymphocytes , 2002, Infection and Immunity.

[24]  C. Isacke,et al.  The mannose receptor family. , 2002, Biochimica et biophysica acta.

[25]  M. Mansour,et al.  Optimal T Cell Responses to Cryptococcus neoformans Mannoprotein Are Dependent on Recognition of Conjugated Carbohydrates by Mannose Receptors1 , 2002, The Journal of Immunology.

[26]  M. Nussenzweig,et al.  Mannose Receptor-Mediated Regulation of Serum Glycoprotein Homeostasis , 2002, Science.

[27]  Yoshinobu Koguchi,et al.  CRYPTOCOCCAL INFECTION AND TH1-TH2 CYTOKINE BALANCE , 2002, International reviews of immunology.

[28]  S. Jalkanen,et al.  Mannose Receptor Is a Novel Ligand for L-Selectin and Mediates Lymphocyte Binding to Lymphatic Endothelium , 2001, The Journal of experimental medicine.

[29]  R. Steinman,et al.  Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. , 2001, International immunology.

[30]  G. Puzo,et al.  Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor1 , 2001, The Journal of Immunology.

[31]  J. Rohrer,et al.  A Di-aromatic Motif in the Cytosolic Tail of the Mannose Receptor Mediates Endosomal Sorting* , 2000, The Journal of Biological Chemistry.

[32]  S. Bauman,et al.  Dendritic Cells in the Induction of Protective and Nonprotective Anticryptococcal Cell-Mediated Immune Responses1 , 2000, The Journal of Immunology.

[33]  G. Schuler,et al.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.

[34]  F. Bistoni,et al.  Encapsulation of Cryptococcus neoformans with Glucuronoxylomannan Inhibits the Antigen-Presenting Capacity of Monocytes , 1998, Infection and Immunity.

[35]  J. Drijfhout,et al.  Mannose receptor‐mediated uptake of antigens strongly enhances HLA class II‐restricted antigen presentation by cultured dendritic cells , 1997, European journal of immunology.

[36]  S. Levitz,et al.  Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans. , 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[37]  G. Huffnagle,et al.  Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. , 1995, American journal of respiratory cell and molecular biology.

[38]  J. Curtis,et al.  Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. , 1995, Journal of immunology.

[39]  G. Huffnagle,et al.  T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice , 1991, Infection and immunity.

[40]  J. Murphy.  Influence of cryptococcal antigens on cell-mediated immunity. , 1988, Reviews of infectious diseases.